RegenOS™ Global Launch: Cell Activation to Tissue Remodeling A New Era of Regenerative Medical
Triangel is dedicated to providing superior medical solutions for healthcare and aesthetic professionals worldwide. RegenOS is a Next-Generation Regenerative Platformintegrating Surgical Precision With Advancedphotobiomodulation Therapy.
Four Wavelengths, Multi-Target Synergistic Regeneration
RegenOS Built upon Triangel's dual-wavelength surgical expertise (980nm + 1470nm) andenhanced with regenerative biomodulation wavelengths (638nm + 658nm), enablingphysicians to target different biological layers - from cellular stimulation to deeptissue remodeling - within one comprehensive system.
Four Wavelengths. Technology
638nm: Cell Activation& Skin Repair
Low-level red lighttherapy enhancescellular metabolismand
658nm: Hair GrowthTissue heal Recovery
Promotes folliclestimulation,inflamimationreduction, andtissue healing.
980nm: Precision Lipolysis&Coagulation
Effective for fatdisruption, deeptissue heatingand hemostasis
1470nm: Deep TissueRegeneration
High water absorptionenables controlledthermal coagulation,stimulating collagenremodeling and tissueregeneration with minimalsurface damage.
20 Days: From Clinical Validation to Patient Perception
RegenOS™'s "20-day return on investment" concept is not just marketing rhetoric, but based on actual clinical observations: from cell activation and tissue remodeling to initial structural regeneration, the entire process can achieve key transformations within 20 days. For medical aesthetic institutions, this translates to shorter patient wait times, higher treatment turnover rates, and greater patient satisfaction.
Multidisciplinary Applicatio One Platform - Multiple Possibilities
This platform has extensive application practices in several of the following areas.
Regenerative Aesthetics (Skin Rejuvenation, Scar Repair)
Minimally Invasive Surgery (Soft Tissue Cutting, Coagulation)
Pain Management and Rehabilitation Medicine
Oral and Otolaryngological Soft Tissue Treatment
"RegenOS™ is a truly multidisciplinary platform that frees physicians from the limitations of a single tool, allowing them to freely select wavelengths, modes, and energy parameters based on the patient's different tissue conditions."
Why Choose RegenOs?
Cost Advantage.
*Lower Investment
*Maximized ROI
*All-in-One System
Strong Clinical Demand
*High-Demand Treatments
*Addresses Core Patient Needs
*Minimal Downtime
*Fast Recovery
Competitive Advantage
*No Direct Competition
*Unique Market Positioning
*Comprehensive & Efficient Treatment Solution
The launch of RegenOS™ marks a new stage in regenerative medicine, moving from "single repair" to "procedural, multi-wavelength, and structure-oriented" approaches. In the future, Triangel will continue to monitor the actual clinical application results and continuously promote the application of the regeneration platform in various disciplines.
